OV Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,751
Closed -$238K 45
2026
Q1
$238K Sell
2,751
-8,373
-75% -$802K 0.49% 26
2025
Q4
$1.07M Hold
11,124
0.93% 22
2025
Q3
$1.06M Buy
11,124
+28
+0.3% +$2.57K 0.9% 24
2025
Q2
$967K Sell
11,096
-16,491
-60% -$1.4M 0.81% 34
2025
Q1
$2.48M Buy
27,587
+5,833
+27% +$522K 1.16% 28
2024
Q4
$1.74M Buy
21,754
+1,697
+8% +$147K 0.81% 34
2024
Q3
$1.81M Buy
20,057
+2,821
+16% +$237K 1.2% 32
2024
Q2
$1.36M Buy
17,236
+236
+1% +$19.3K 0.95% 44
2024
Q1
$1.48M Hold
17,000
1.07% 39
2023
Q4
$1.41M Buy
+17,000
New +$1.3M 1.17% 36

Other funds holding MDT

OV Management's MDT Position: Q2 2026 in Review

OV Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,751 shares — an estimated $238K sold.

OV Management first reported a position in MDT in Q4 2023 and held it in 10 quarters. The position peaked at $2.48M in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • OV Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • OV Management sold 2,751 Medtronic shares in Q2 2026, an estimated $238K.
  • OV Management first reported a position in Medtronic in Q4 2023 and held it in 10 quarters.
  • OV Management's Medtronic position peaked at $2.48M in Q1 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on OV Management's 13F filing for Q2 2026, filed 10 Aug 2026.